Uroxatral

Product NDC
59212-200
11-digit product format
592120200
Labeler code
59212
Product ID
59212-200_ffbc758d-7556-4269-8947-baa7ddb88541
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Alfuzosin HCl
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Labeler
Advanz Pharma (US) Corp.
Application
NDA021287
Marketing category
NDA
Marketing start
2013-06-03
Substance
ALFUZOSIN HYDROCHLORIDE
Active strength
10 mg/1
Pharmacologic classes
Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N021287-001UROXATRALALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALABRLD, RS2003-06-12

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
N021287-001AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02N021287-001UROXATRAL10MGTABLET, EXTENDED RELEASE / ORALABRLD, RS2003-06-12011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021287-001UROXATRAL10MGTABLET, EXTENDED RELEASE / ORALABRLD, RS2003-06-1231067a03dcf5…
2025-08-23 18:47 UTC2025-08N021287-001UROXATRAL10MGTABLET, EXTENDED RELEASE / ORALABRLD, RS2003-06-126a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021287-001UROXATRAL10MGTABLET, EXTENDED RELEASE / ORALABRLD, RS2003-06-12fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N021287-001UROXATRAL10MGTABLET, EXTENDED RELEASE / ORALABRLD, RS2003-06-12b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N021287-001UROXATRAL10MGTABLET, EXTENDED RELEASE / ORALABRLD, RS2003-06-1203ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N021287-001UROXATRAL10MGTABLET, EXTENDED RELEASE / ORALABRLD, RS2003-06-122680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N021287-001UROXATRAL10MGTABLET, EXTENDED RELEASE / ORALABRLD, RS2003-06-125bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N021287-001UROXATRAL10MGTABLET, EXTENDED RELEASE / ORALABRLD, RS2003-06-12d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N021287-001UROXATRAL10MGTABLET, EXTENDED RELEASE / ORALABRLD, RS2003-06-12d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N021287-001UROXATRAL10MGTABLET, EXTENDED RELEASE / ORALABRLD, RS2003-06-1279d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N021287-001UROXATRAL10MGTABLET, EXTENDED RELEASE / ORALABRLD, RS2003-06-12301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N021287-001UROXATRAL10MGTABLET, EXTENDED RELEASE / ORALABRLD, RS2003-06-121e350fbaab3a…
2024-05-31 18:47 UTC2024-05N021287-001UROXATRAL10MGTABLET, EXTENDED RELEASE / ORALABRLD, RS2003-06-128072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N021287-001UROXATRAL10MGTABLET, EXTENDED RELEASE / ORALABRLD, RS2003-06-125c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N021287-001UROXATRAL10MGTABLET, EXTENDED RELEASE / ORALABRLD, RS2003-06-125d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N021287-001UROXATRAL10MGTABLET, EXTENDED RELEASE / ORALABRLD, RS2003-06-124b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N021287-001UROXATRAL10MGTABLET, EXTENDED RELEASE / ORALABRLD, RS2003-06-1274a2ff9319b5…
2022-03-09 01:35 UTC2022-03N021287-001UROXATRAL10MGTABLET, EXTENDED RELEASE / ORALABRLD, RS2003-06-12bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N021287-001UROXATRAL10MGTABLET, EXTENDED RELEASE / ORALABRLD, RS2003-06-12782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N021287-001UROXATRAL10MGTABLET, EXTENDED RELEASE / ORALABRLD, RS2003-06-1287673890dc5c…
2021-03-12 10:30 UTC2021-03N021287-001UROXATRAL10MGTABLET, EXTENDED RELEASE / ORALABRLD, RS2003-06-125aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N021287-001UROXATRAL10MGTABLET, EXTENDED RELEASE / ORALABRLD, RS2003-06-128869cabd3fbd…
2020-11-12 02:37 UTC2020-11N021287-001UROXATRAL10MGTABLET, EXTENDED RELEASE / ORALABRLD, RS2003-06-12c0c555d07b60…
2019-12-14 00:12 UTC2019-12N021287-001UROXATRAL10MGTABLET, EXTENDED RELEASE / ORALABRLD, RS2003-06-123f01610625f2…
2019-09-15 20:21 UTC2019-09N021287-001UROXATRAL10MGTABLET, EXTENDED RELEASE / ORALABRLD, RS2003-06-12b00525d2431f…
2019-07-19 19:46 UTC2019-07N021287-001UROXATRAL10MGTABLET, EXTENDED RELEASE / ORALABRLD, RS2003-06-12ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N021287-001UROXATRAL10MGTABLET, EXTENDED RELEASE / ORALABRLD, RS2003-06-126a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N021287-001UROXATRAL10MGTABLET, EXTENDED RELEASE / ORALABRLD, RS2003-06-121c564ffb4f44…
2023-12-20 04:57 UTC2023-12N021287-001UROXATRAL10MGTABLET, EXTENDED RELEASE / ORALABRLD, RS2003-06-12ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N021287-001UROXATRAL10MGTABLET, EXTENDED RELEASE / ORALABRLD, RS2003-06-12a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N021287-001UROXATRAL10MGTABLET, EXTENDED RELEASE / ORALABRLD, RS2003-06-129b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N021287-001UROXATRAL10MGTABLET, EXTENDED RELEASE / ORALABRLD, RS2003-06-12a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N021287-001UROXATRAL10MGTABLET, EXTENDED RELEASE / ORALABRLD, RS2003-06-123f0d92c62455…
2023-05-13 08:27 UTC2023-05N021287-001UROXATRAL10MGTABLET, EXTENDED RELEASE / ORALABRLD, RS2003-06-12053a50430f4f…
2023-01-26 05:58 UTC2023-01N021287-001UROXATRAL10MGTABLET, EXTENDED RELEASE / ORALABRLD, RS2003-06-123bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N021287-001UROXATRAL10MGTABLET, EXTENDED RELEASE / ORALABRLD, RS2003-06-123a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N021287-001UROXATRAL10MGTABLET, EXTENDED RELEASE / ORALABRLD, RS2003-06-12f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09N021287-001UROXATRAL10MGTABLET, EXTENDED RELEASE / ORALABRLD, RS2003-06-12e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N021287-001UROXATRAL10MGTABLET, EXTENDED RELEASE / ORALABRLD, RS2003-06-12cb3db0bc1861…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-02-19 14:30 UTC2026-02N021287-001AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021287-001AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08N021287-001AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021287-001AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N021287-001AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N021287-001AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N021287-001AB12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N021287-001AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N021287-001AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N021287-001AB1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N021287-001AB179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N021287-001AB1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N021287-001AB11e350fbaab3a…
2024-05-31 18:47 UTC2024-05N021287-001AB18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N021287-001AB15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N021287-001AB15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N021287-001AB14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N021287-001AB174a2ff9319b5…
2022-03-09 01:35 UTC2022-03N021287-001AB1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N021287-001AB1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N021287-001AB187673890dc5c…
2021-03-12 10:30 UTC2021-03N021287-001AB15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N021287-001AB18869cabd3fbd…
2020-11-12 02:37 UTC2020-11N021287-001AB1c0c555d07b60…
2019-12-14 00:12 UTC2019-12N021287-001AB13f01610625f2…
2019-09-15 20:21 UTC2019-09N021287-001AB1b00525d2431f…
2019-07-19 19:46 UTC2019-07N021287-001AB1ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N021287-001AB16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N021287-001AB11c564ffb4f44…
2023-12-20 04:57 UTC2023-12N021287-001AB1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N021287-001AB1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N021287-001AB19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N021287-001AB1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N021287-001AB13f0d92c62455…
2023-05-13 08:27 UTC2023-05N021287-001AB1053a50430f4f…
2023-01-26 05:58 UTC2023-01N021287-001AB13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N021287-001AB13a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N021287-001AB1f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09N021287-001AB1e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N021287-001AB1cb3db0bc1861…

Additional Listing Data#

Finished product
Yes
Brand name base
Uroxatral
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
ALFUZOSIN HYDROCHLORIDE10 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
75046A1XTNInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
861132Internal RxNorm lookup
861134Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
9fc7f119-f36b-44cf-945d-940160f3afe3Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
8b671e1a-6f8a-5de4-69a7-83132df7952dProduct name320201015

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
59212-200-10Uroxatral100 in 1 BOTTLETABLET, EXTENDED RELEASE1009
59212-200-30Uroxatral30 in 1 BOTTLETABLET, EXTENDED RELEASE309

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
59212-200-10EA - Each59212-200849e6e99-7b1b-4f99-9c34-9cfd9f8025e912015-12-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
alfuzosin hydrochlorideACTIVE INGREDIENT75046A1XTNUROXATRAL (ALFUZOSIN HCL) TABLET, EXTENDED RELEASE [CONCORDIA PHARMACEUTICALS INC.]1
alfuzosinACTIVE MOIETY90347YTW5FUROXATRAL (ALFUZOSIN HCL) TABLET, EXTENDED RELEASE [CONCORDIA PHARMACEUTICALS INC.]1
cellulose, microcrystallineINACTIVE INGREDIENTOP1R32D61UUROXATRAL (ALFUZOSIN HCL) TABLET, EXTENDED RELEASE [CONCORDIA PHARMACEUTICALS INC.]1
ethylcellulose (100 mpa.s)INACTIVE INGREDIENT47MLB0F1MVUROXATRAL (ALFUZOSIN HCL) TABLET, EXTENDED RELEASE [CONCORDIA PHARMACEUTICALS INC.]1
ferric oxide yellowINACTIVE INGREDIENTEX438O2MRTUROXATRAL (ALFUZOSIN HCL) TABLET, EXTENDED RELEASE [CONCORDIA PHARMACEUTICALS INC.]1
hydrogenated castor oilINACTIVE INGREDIENTZF94AP8MEYUROXATRAL (ALFUZOSIN HCL) TABLET, EXTENDED RELEASE [CONCORDIA PHARMACEUTICALS INC.]1
hypromellosesINACTIVE INGREDIENT3NXW29V3WOUROXATRAL (ALFUZOSIN HCL) TABLET, EXTENDED RELEASE [CONCORDIA PHARMACEUTICALS INC.]1
magnesium stearateINACTIVE INGREDIENT70097M6I30UROXATRAL (ALFUZOSIN HCL) TABLET, EXTENDED RELEASE [CONCORDIA PHARMACEUTICALS INC.]1
mannitolINACTIVE INGREDIENT3OWL53L36AUROXATRAL (ALFUZOSIN HCL) TABLET, EXTENDED RELEASE [CONCORDIA PHARMACEUTICALS INC.]1
povidonesINACTIVE INGREDIENTFZ989GH94EUROXATRAL (ALFUZOSIN HCL) TABLET, EXTENDED RELEASE [CONCORDIA PHARMACEUTICALS INC.]1
silicon dioxideINACTIVE INGREDIENTETJ7Z6XBU4UROXATRAL (ALFUZOSIN HCL) TABLET, EXTENDED RELEASE [CONCORDIA PHARMACEUTICALS INC.]1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
59212-200UROXATRAL (ALFUZOSIN HCL) TABLET, EXTENDED RELEASE [ADVANZ PHARMA (US) CORP.]9Current NDC, Legacy NDC, 2 package rows20250103_9fc7f119-f36b-44cf-945d-940160f3afe3.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
UroxatralALFUZOSIN HCLAdvanz Pharma (US) Corp.9fc7f119-f36b-44cf-945d-940160f3afe32024-12-05Warnings, Adverse reactionsExact identifier
application applno (NDA): 021287
application number: NDA021287
ndc (product): 59212-200

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
861132alfuzosin HCl 10 MG 24HR Extended Release Oral TabletPSN9fc7f119-f36b-44cf-945d-940160f3afe39
861134Uroxatral 10 MG 24HR Extended Release Oral TabletPSN9fc7f119-f36b-44cf-945d-940160f3afe39
86113424 HR alfuzosin hydrochloride 10 MG Extended Release Oral Tablet [UroXatral]SBD9fc7f119-f36b-44cf-945d-940160f3afe39
86113224 HR alfuzosin hydrochloride 10 MG Extended Release Oral TabletSCD9fc7f119-f36b-44cf-945d-940160f3afe39
86113424 HR UroXatral 10 MG Extended Release Oral TabletSY9fc7f119-f36b-44cf-945d-940160f3afe39
861132alfuzosin hydrochloride 10 MG 24 HR Extended Release Oral TabletSY9fc7f119-f36b-44cf-945d-940160f3afe39
861134Uroxatral 10 MG 24 HR Extended Release Oral TabletSY9fc7f119-f36b-44cf-945d-940160f3afe39

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
59212-200-1059212020010100 TABLET, EXTENDED RELEASE in 1 BOTTLE (59212-200-10) 2013-06-030000-00-00NoNoCurrent
59212-200-305921202003030 TABLET, EXTENDED RELEASE in 1 BOTTLE (59212-200-30) 2019-01-180000-00-00NoNoCurrent